Improving Healthcare, Reducing Costs & Saving Lives
Smart contract blockchain
Nicholas James Rumble - Chief Executive Officer (CEO)
Chris Matey - Chief Financial Officer (CFO)
Darran Trute - Chief Technology Officer (CTO)
Andrey Verbitsky - ICO Director
Luke Lerdal - Chief Data Officer (CDO)
We’re solving an enormous real-world problem by helping patients take their medications properly
Every day, millions of people fail to take their medications as prescribed and the resulting personal and financial costs are staggering. Worldwide, non-adherence results in $700 billion in avoidable medical costs.
The data we create is unique and has enormous value to pharmaceutical companies, researchers and governments.
Every time a patient uses our CuraServe technology, our data grows in utility and value.
Curaizon™ solves drug non-adherence problem by deploying our technology through national health services. As part of our solution, we collect fully anonymized data about how and when patients take medications.
CuraTokens™ are the only way to access our data. Tokens can be redeemed to access the data, which will advance medical research, drive down healthcare costs and save lives.
The value of a CuraToken™ is based on a real solution to a real problem.
Curaizon aims to create a platform where patients can manage their doses and access their medications and improve their overall health while reducing the cost of the healthcare in the long run. It has created CuraServe a program for the same purpose earlier stated. The team has members who are professionals in their fields and have high ICO success rates and the overall team evaluation is positive. The website is neatly designed and has all the required information provided. The whitepaper has everything explained deeply and clearly. The roadmap seems practical and well thought, overall the project seems great and doesn't look like a scam.
User ReviewWrite review 1 reviews
A blockchain based medical healthcare is what Curaizon aims to provide which according to me is really great and unique concept as there is almost everyone who will be benefitted from this and as the medical industry is a huge one I think it will be a great success if advertised properly. All the other aspects such as its team, whitepaper, roadmap all seem great and well presented. I would surely invest in it if I had to.
You need to login to create review.